A pilot study to evaluate the vascular endothelial growth factor receptor tyrosine kinase inhibitor AZD2171 and chemotherapy in locally advanced and inflammatory breast cancer

Clin Breast Cancer. 2005 Dec;6(5):460-3. doi: 10.3816/CBC.2005.n.052.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / etiology
  • Clinical Trials, Phase II as Topic
  • Enzyme Inhibitors / adverse effects
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Humans
  • Inflammation / drug therapy
  • Pilot Projects
  • Quinazolines / adverse effects
  • Quinazolines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors*

Substances

  • Enzyme Inhibitors
  • Quinazolines
  • Receptors, Vascular Endothelial Growth Factor
  • cediranib